What is the current market size and future outlook for the bioelectric medicine market?
The bioelectric medicine market size has grown strongly in recent years. It will grow from $24.69 billion in 2024 to $27.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing geriatric population, increasing disposable income, increasing demand for add-on therapy, increasing prevalence of neurological disorders, and increasing demand for cutting edge therapeutics.
The bioelectric medicine market size is expected to see strong growth in the next few years. It will grow to $38.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growing demand for non-invasive treatment, increasing healthcare expenditure, growing patient population, high prevalence of chronic diseases, and increasing awareness about healthcare innovations. Major trends in the forecast period include technological advancements, integration of telemedicine and digital health, increasing investment and funding, advancements in implantable devices, and miniaturization of devices.
Get Your Free Sample of The Global Bioelectric Medicine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15523&type=smp
How has the bioelectric medicine market evolved, and what factors have shaped its growth?
The increasing healthcare expenditure is expected to propel the growth of the bioelectric medicine market going forward. Healthcare expenditure is the total amount of money spent on healthcare services and resources within a given time frame. The increase in healthcare expenditure is fueled by factors such as population aging, advancements in medical technology, and rising chronic disease prevalence. The increasing healthcare expenditure positively impacts bioelectric medicine by fostering greater investment in research, development, and adoption of innovative bioelectric therapies. For instance, in 2022, according to the Office for National Statistics, a UK-based national statistical institute, UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, reflecting an increase of 0.7% compared to spending in 2021. Therefore, the increasing healthcare expenditure will drive the bioelectric medicine market going forward.
What are the major segments of the bioelectric medicine market?
The bioelectric medicine market covered in this report is segmented –
1) By Type: Implantable Electroceutical Devices, Non-Invasive Electroceutical Devices
2) By Product: Implantable Cardioverter-Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators (TENS), Sacral Nerve Stimulators, Vagus Nerve Stimulators, Other Products
3) By Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Treatment-Resistant Depression, Epilepsy, Other Applications
4) By End Use: Hospitals, Other End Uses
Subsegments:
1) By Implantable Electroceutical Devices: Cochlear Implants, Deep Brain Stimulation (DBS) Devices, Spinal Cord Stimulation (SCS) Devices, Vagus Nerve Stimulation (VNS) Devices, Retinal Implants, Neuromodulation Devices
2) By Non-Invasive Electroceutical Devices: Transcranial Magnetic Stimulation (TMS) Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Electrotherapy Devices, Pulsed Electromagnetic Field (PEMF) Therapy Devices, Electroceutical Wearables
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/bioelectric-medicine-global-market-report
Which companies dominate the bioelectric medicine market?
Major companies operating in the bioelectric medicine market are Abbott Laboratories, Medtronic PLC, Koninklijke Philips N.V., Boston Scientific Corporation, Biotronik SE & Co. KG, Cochlear Ltd., LivaNova PLC, Bioventus LLC, Inspire Medical Systems Inc., Nevro Corporation, Axonics Inc., Zynex Inc., NeuroPace Inc., Stimwave LLC, Setpoint Medical Corporation, ReShape Lifesciences Inc., ElectroCore Inc., NeuroMetrix Inc., Soterix Medical Inc., Galvani Bioelectronics, MicroTransponder Inc., BioElectronics Corporation, Cerbomed GmbH
How will evolving trends contribute to the growth of the bioelectric medicine market?
Major companies operating in the bioelectric medicine market are focusing on technological advancements such as software-enabled general wellness bioelectric medicines to gain a competitive advantage. The software-enabled general wellness medicine gives users precise guidance for deep brain stimulation therapy procedures and aids in surgical planning, intra-operative electrode placement, and customized programming for deep brain stimulation therapy. For instance, In July 2023, Boston Scientific Corporation, a US-based bioelectric medicine and wellness company, announced that Vercise Neural Navigator 5 Software had received approval from the US FDA. This software provides advanced features for precise targeting and programming of deep brain stimulation (DBS) therapy. It integrates imaging data with stimulation parameters, allowing for tailored treatment of neurological disorders. This leads to accurate electrode placement, precise guidance in surgical planning, and customized programming, ultimately enhancing treatment outcomes and patient satisfaction.
What are the key regional dynamics of the bioelectric medicine market, and which region leads in market share?
North America was the largest region in the bioelectric medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioelectric medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Bioelectric Medicine Market Report 2025 Offer?
The bioelectric medicine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Bioelectric medicine, also known as electroceuticals or bioelectronic medicine, is a medical science field that focuses on using electrical signals to modulate the body’s nervous system to treat various diseases and conditions. This approach involves devices that generate precise electrical impulses to influence nerve activity, restore normal function, and promote healing in targeted body areas.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15523
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
